A former executive for Pfizer, recently tasked with joining HHS to help reduce the prices of Big Pharmas monopoly prescription medications, was found bludgeoned to death outside his Washington D.C. apartment. Local police ruled the death of Daniel Best a suicide, raising immediate questions about how an individual can bludgeon himself to death with multiple blows.